Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.
In the last several years, global market of Rho Associated Protein Kinase 2 developed rapidly, with an average growth rate of 68%. In 2017, Global Market Size of Rho Associated Protein Kinase 2 is nearly 850 K USD.
For developing product, there are 1 product in Phase 3, 2 products in Phase 2, 0 products in Phase 1 and 6 products in Preclinical. The total investment for Rho Associated Protein Kinase 2 developing is around 88 M USD in 2017.
The Application of Rho Associated Protein Kinase 2 includes Glaucoma, Spinal Cord, Chronic Obstructive Pulmonary Disease, Immune Therapy and Others, and the proportion of R&D Investmen for Glaucoma in 2017 is about 67%, and the proportion is in decrease trend from 2012 to 2016.
According to this study, over the next five years the Rho Associated Protein Kinase 2 market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rho Associated Protein Kinase 2 business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rho Associated Protein Kinase 2 market by product type, application, key manufacturers and key regions and countries.
This study considers the Rho Associated Protein Kinase 2 value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Glaucoma
Spinal Cord
Chronic Obstructive Pulmonary Disease
Immune Therapy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Aerie Pharmaceuticals
Kadmon Corporation
BioAxone BioSciences Inc
Redx Pharma
Angion Biomedica
DWTI
HitGen LTD
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rho Associated Protein Kinase 2 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rho Associated Protein Kinase 2 market by identifying its various subsegments.
Focuses on the key global Rho Associated Protein Kinase 2 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rho Associated Protein Kinase 2 with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rho Associated Protein Kinase 2 submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Rho Associated Protein Kinase 2 Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rho Associated Protein Kinase 2 Consumption 2014-2024
2.1.2 Rho Associated Protein Kinase 2 Consumption CAGR by Region
2.2 Rho Associated Protein Kinase 2 Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Rho Associated Protein Kinase 2 Consumption by Type
2.3.1 Global Rho Associated Protein Kinase 2 Consumption Market Share by Type (2014-2019)
2.3.2 Global Rho Associated Protein Kinase 2 Revenue and Market Share by Type (2014-2019)
2.3.3 Global Rho Associated Protein Kinase 2 Sale Price by Type (2014-2019)
2.4 Rho Associated Protein Kinase 2 Segment by Application
2.4.1 Glaucoma
2.4.2 Spinal Cord
2.4.3 Chronic Obstructive Pulmonary Disease
2.4.4 Immune Therapy
2.4.5 Others
2.5 Rho Associated Protein Kinase 2 Consumption by Application
2.5.1 Global Rho Associated Protein Kinase 2 Consumption Market Share by Application (2014-2019)
2.5.2 Global Rho Associated Protein Kinase 2 Value and Market Share by Application (2014-2019)
2.5.3 Global Rho Associated Protein Kinase 2 Sale Price by Application (2014-2019)
3 Global Rho Associated Protein Kinase 2 by Players
3.1 Global Rho Associated Protein Kinase 2 Sales Market Share by Players
3.1.1 Global Rho Associated Protein Kinase 2 Sales by Players (2017-2019)
3.1.2 Global Rho Associated Protein Kinase 2 Sales Market Share by Players (2017-2019)
3.2 Global Rho Associated Protein Kinase 2 Revenue Market Share by Players
3.2.1 Global Rho Associated Protein Kinase 2 Revenue by Players (2017-2019)
3.2.2 Global Rho Associated Protein Kinase 2 Revenue Market Share by Players (2017-2019)
3.3 Global Rho Associated Protein Kinase 2 Sale Price by Players
3.4 Global Rho Associated Protein Kinase 2 Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Rho Associated Protein Kinase 2 Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Rho Associated Protein Kinase 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Rho Associated Protein Kinase 2 by Regions
4.1 Rho Associated Protein Kinase 2 by Regions
4.1.1 Global Rho Associated Protein Kinase 2 Consumption by Regions
4.1.2 Global Rho Associated Protein Kinase 2 Value by Regions
4.2 Americas Rho Associated Protein Kinase 2 Consumption Growth
4.3 APAC Rho Associated Protein Kinase 2 Consumption Growth
4.4 Europe Rho Associated Protein Kinase 2 Consumption Growth
4.5 Middle East & Africa Rho Associated Protein Kinase 2 Consumption Growth
5 Americas
5.1 Americas Rho Associated Protein Kinase 2 Consumption by Countries
5.1.1 Americas Rho Associated Protein Kinase 2 Consumption by Countries (2014-2019)
5.1.2 Americas Rho Associated Protein Kinase 2 Value by Countries (2014-2019)
5.2 Americas Rho Associated Protein Kinase 2 Consumption by Type
5.3 Americas Rho Associated Protein Kinase 2 Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Rho Associated Protein Kinase 2 Consumption by Countries
6.1.1 APAC Rho Associated Protein Kinase 2 Consumption by Countries (2014-2019)
6.1.2 APAC Rho Associated Protein Kinase 2 Value by Countries (2014-2019)
6.2 APAC Rho Associated Protein Kinase 2 Consumption by Type
6.3 APAC Rho Associated Protein Kinase 2 Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Rho Associated Protein Kinase 2 by Countries
7.1.1 Europe Rho Associated Protein Kinase 2 Consumption by Countries (2014-2019)
7.1.2 Europe Rho Associated Protein Kinase 2 Value by Countries (2014-2019)
7.2 Europe Rho Associated Protein Kinase 2 Consumption by Type
7.3 Europe Rho Associated Protein Kinase 2 Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Rho Associated Protein Kinase 2 by Countries
8.1.1 Middle East & Africa Rho Associated Protein Kinase 2 Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Rho Associated Protein Kinase 2 Value by Countries (2014-2019)
8.2 Middle East & Africa Rho Associated Protein Kinase 2 Consumption by Type
8.3 Middle East & Africa Rho Associated Protein Kinase 2 Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rho Associated Protein Kinase 2 Distributors
10.3 Rho Associated Protein Kinase 2 Customer
11 Global Rho Associated Protein Kinase 2 Market Forecast
11.1 Global Rho Associated Protein Kinase 2 Consumption Forecast (2019-2024)
11.2 Global Rho Associated Protein Kinase 2 Forecast by Regions
11.2.1 Global Rho Associated Protein Kinase 2 Forecast by Regions (2019-2024)
11.2.2 Global Rho Associated Protein Kinase 2 Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Rho Associated Protein Kinase 2 Forecast by Type
11.8 Global Rho Associated Protein Kinase 2 Forecast by Application
12 Key Players Analysis
12.1 Aerie Pharmaceuticals
12.1.1 Company Details
12.1.2 Rho Associated Protein Kinase 2 Product Offered
12.1.3 Aerie Pharmaceuticals Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Aerie Pharmaceuticals News
12.2 Kadmon Corporation
12.2.1 Company Details
12.2.2 Rho Associated Protein Kinase 2 Product Offered
12.2.3 Kadmon Corporation Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Kadmon Corporation News
12.3 BioAxone BioSciences Inc
12.3.1 Company Details
12.3.2 Rho Associated Protein Kinase 2 Product Offered
12.3.3 BioAxone BioSciences Inc Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 BioAxone BioSciences Inc News
12.4 Redx Pharma
12.4.1 Company Details
12.4.2 Rho Associated Protein Kinase 2 Product Offered
12.4.3 Redx Pharma Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Redx Pharma News
12.5 Angion Biomedica
12.5.1 Company Details
12.5.2 Rho Associated Protein Kinase 2 Product Offered
12.5.3 Angion Biomedica Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Angion Biomedica News
12.6 DWTI
12.6.1 Company Details
12.6.2 Rho Associated Protein Kinase 2 Product Offered
12.6.3 DWTI Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 DWTI News
12.7 HitGen LTD
12.7.1 Company Details
12.7.2 Rho Associated Protein Kinase 2 Product Offered
12.7.3 HitGen LTD Rho Associated Protein Kinase 2 Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 HitGen LTD News
...
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Rho Associated Protein Kinase 2
Table Product Specifications of Rho Associated Protein Kinase 2
Figure Rho Associated Protein Kinase 2 Report